Dr John A Reynolds MRCP, PhD

Dr John Reynolds

Institute of Inflammation and Ageing
Clinical Senior Lecturer in Rheumatology

Contact details

University of Birmingham Research Labs
1st Floor
Queen Elizabeth Hospital
B15 2WB


PhD (Medicine), University of Manchester 2014

MRCP (UK) 2008

MBChB (with Honours), University of Birmingham 2005

BMedSc (Hons), University of Birmingham 2002


John Reynolds is a Clinical Senior Lecturer in Rheumatology at the University of Birmingham and an Honorary Consultant Rheumatologist at Sandwell and West Birmingham Hospitals NHS Trust.

John qualified from the University of Birmingham in 2005 and became a Member of the Royal College of Physicians in 2008.  After completing an Academic Foundation Programme in Birmingham in 2007 he moved to Manchester as an NIHR Academic Clinical Fellow and subsequently an NIHR Academic Clinical Lecturer.  Between 2010 and 2014 he completed a North West England MRC Clinical Pharmacology and Therapeutics Clinical Research Training Fellowship which included 3 months as a visiting scientist at the National Institutes of Health (NIH).  In 2018 he was awarded a Certificate in Human Pharmacology by the RCP Faculty of Pharmaceutical Medicine.


  • Clinical Senior Lecturer in Rheumatology and Honorary Consultant Rheumatologist
  • Consultant Rheumatologist


Recent publications


Ibrahim, S, Edwards, CJ, Ehrenstein, M, Griffiths, B, Gordon, C, Hewins, P, Jayne, D, Lightstone, L, McLaren, Z, Rhodes, B, Vital, E & Reynolds, J 2024, 'Differences in management approaches for lupus nephritis within the UK', Rheumatology Advances in Practice, vol. 8, no. 1, rkae017. https://doi.org/10.1093/rap/rkae017

OMERACT SLE Working Group, Nielsen, W, Strand, V, Simon, L, Parodis, I, Kim, A, Desai, M, Enman, Y, Wallace, D, Chaichian, Y, Navarra, S, Aranow, C, MacKay, M, Trotter, K, Tayer-Shifman, O, Duarte-Garcia, A, Tam, LS, Ugarte-Gil, M, PonsEstel, G, Reynolds, J, Nikpour, M, Hoi, A, Romero-Diaz, J, Papachristos, D, Aggarwal, A, Mok, CC, Fujio, K, Ramsey-Goldman, R, Howe, A, Nowrouzi, B, Bonilla, D, Thumboo, J, Mosca, M, Aringer, M, Johnson, S, Drucker, A, Morand, E, Bruce, I & Touma, Z 2024, 'OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set', Seminars in arthritis and rheumatism, vol. 65, 152380. https://doi.org/10.1016/j.semarthrit.2024.152380

Reynolds, JA, Faustini, SE, Tosounidou, S, Plant, T, Ubhi, M, Gilman, R, Richter, AG & Gordon, C 2023, 'Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE', Lupus, vol. 32, no. 3, pp. 431-437. https://doi.org/10.1177/09612033231151603

Akhtar, M, Nair, N, Carter, L, Vital, E, Sutton, E, McHugh, N, British Isles Lupus Assessment Group Biologics Register (BILAG BR) Consortium, MASTERPLANS Consortium, Bruce, I & Reynolds, J 2023, 'Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil', Arthritis Research & Therapy, vol. 25, no. 1, 111. https://doi.org/10.1186/s13075-023-03089-5

David, T, Su, L, Chen, Y, Gordon, C, Parker, B, Isenberg, D, Reynolds, J, Bruce, I, International Collaborating Clinics Consortium & MASTERPLANS Consortium 2023, 'Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort', Lupus. https://doi.org/10.1177/09612033231183273

Su, K, Reynolds, J, Reed, R, Da Silva, R, Kelsall, J, Baricevic-Jones, I, Lee, D, Whetton, AD, Geifman , N, McHugh, N, MASTERPLANS and BILAG-BR consortia & Bruce, I 2023, 'Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus', Clinical Proteomics, vol. 20, no. 1, 29. https://doi.org/10.1186/s12014-023-09420-1

Dyball, S, Reynolds, J, Herrick, A, Haque, S, Chinoy, H, Bruce, E, Naz, S, Parker, B & Bruce, I 2022, 'Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort', Rheumatology. https://doi.org/10.1093/rheumatology/keac680

Sharma-Oates, A, Zemedikun, D, Kumar, K, Reynolds, J, Jain, A, Raza, K, Williams, J, Bravo Merodio, L, Roth Cardoso, V, Gkoutos, G, Nirantharakumar, K & Lord, J 2022, 'Early onset of immune-mediated diseases in minority ethnic groups in the UK', BMC medicine, vol. 20, no. 1, 346. https://doi.org/10.1186/s12916-022-02544-5

Carter, LM, Alase, A, Wigston, Z, Psarras, A, Burska, A, Sutton, E, Md Yusof, MY, Reynolds, J, McHugh, N, Emery, P, Wittmann, M, Bruce, I & Vital, E 2022, 'Gene expression and autoantibody analysis reveals distinct ancestry-specific profiles associated with response to rituximab in refractory systemic lupus erythematosus', Arthritis and Rheumatology. https://doi.org/10.1002/art.42404

Reynolds, J, Gayed, M, Khamashta, MA, Leone, F, Toescu, V, Bruce, IN, Giles, I, Teh, L-S, McHugh, N, Mohammed, A, Edwards, CJ & Gordon, C 2022, 'Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine', Rheumatology (Oxford), pp. 1-12. https://doi.org/10.1093/rheumatology/keac372


British Isles Lupus Assessment Group Biologics Register (BILAG BR) Consortium & MASTERPLANS Consortium 2023, 'Correction: Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil', Arthritis Research & Therapy, vol. 25, no. 1, 160. https://doi.org/10.1186/s13075-023-03160-1

Review article

Singh, M, Wambua, S, Lee, SI, Okoth, K, Wang, Z, Fayaz, FFA, Eastwood, K-A, Nelson-Piercy, C, Reynolds, JA, Nirantharakumar, K & Crowe, F 2024, 'Autoimmune diseases and adverse pregnancy outcomes: an umbrella review', BMC medicine, vol. 22, no. 1, 94. https://doi.org/10.1186/s12916-024-03309-y

Su, K, Roberts, C, Heagerty, A & Reynolds, J 2024, 'Insights into the Cellular Basis of Skin Inflammation in Systemic Autoimmune Rheumatic Diseases (SARDs) from Single-Cell technologies', Clinical and Experimental Rheumatology.

Dubey, S, Joshi, N, Stevenson, O, Gordon, C & Reynolds, J 2022, 'Chilblains in immune mediated inflammatory diseases: a review', Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keac231

Shaharir, S, Gordon, C & Reynolds, J 2022, 'Glucocorticoid-free treatment of systemic lupus erythematosus: is it feasible?', Indian Journal of Rheumatology. https://doi.org/10.4103/injr.injr_97_22

View all publications in research portal